Canaan Partners

Type: Company
Name: Canaan Partners
First reported 13 hours ago - Updated 13 hours ago - 1 reports

Liquidia Technologies Debuts Pharmaceutical Company

Liquidia Technologies reported the formation of a new pharmaceutical company, Lq3 Pharmaceuticals. In a release, the Company noted that by leveraging the Particle Replication In Non-Wetting Templates technology, Lq3 will initially focus on research and ... [Published Individual.com - 13 hours ago]
First reported Sep 15 2014 - Updated 18 hours ago - 1 reports

Parkinson's biotech Civitas Therapeutics sets terms for $75 million IPO

Civitas Therapeutics, a biotech developing a therapy for re-emerging symptoms of Parkinson's disease, announced terms for its IPO on Monday. The Chelsea, MA-based company plans to raise $75 million by offering 5.0 million shares at a price range of $14 ... [Published Renaissance Capital - Sep 15 2014]
First reported Sep 15 2014 - Updated 22 hours ago - 1 reports

Fitterli wins Intel Business Challenge Europe

The Israeli start-up allows users to virtually try clothes on using a simulated 3D avatar.Vilnius Lithuania, September 12, 2014 - Israeli start-up Fitterli, which is introducing a new way to shop for clothing online, won first place in Intel’s Business ... [Published Globes - Sep 15 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 4 reports

Liquidia Launches Lq3 Pharmaceuticals With $10M Series A

(c) 2014 Dow Jones & Company, Inc.Venture-backed Liquidia Technologies Inc . has launched a new drug company, Lq3 Pharmaceuticals, to advance oral-health therapies with $10 million in Series A financing.Canaan Partners , an investor in Liquidia as well ... [Published Dow Jones Financial Information Services - Sep 10 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 2 reports

7 start-ups advance to The Pitch finals [Globes, Tel Aviv, Israel :: ]

09/09/2014 10:00 AM ET09/09/2014 9:00 AM ET09/09/2014 9:00 AM ETSept. 10--Last Thursday, dozens of the leading figures in Israeli high-tech gathered in Herzliya Pituah to select the next generation of start-ups. Of the twenty companies that went on stage ... [Published BusinessWeek - Sep 10 2014]
First reported Sep 09 2014 - Updated Sep 10 2014 - 1 reports

Rakuten buys Ebates for USD 1 bln cash

Rakuten said it has agreed to acquire Ebates for a total of USD 1 billion in cash from shareholders August Capital Foundation Capital Management, and Canaan Partners. Rakuten said it will finance the buy from cash at hand as well as from either bank borrowings, ... [Published Telecompaper - Sep 09 2014]
First reported Aug 27 2014 - Updated Aug 28 2014 - 2 reports

Civitas Therapeutics Completes $55M in Series C Financing

Civitas Therapeutics reported the successful completion of a $55 million Series C financing. According to a release from the company, the financing round included new investors Adage Capital Management, OrbiMed Advisors, Partner Fund Management, Rock ... [Published Individual.com - Aug 28 2014]
First reported Aug 25 2014 - Updated Aug 26 2014 - 3 reports

Civitas Therapeutics scores $55 mln Series C

Civitas Therapeutics has closed $55 million in Series C funding. The investors included Adage Capital Management, OrbiMed Advisors, Partner Fund Management, Rock Springs Capital, Sofinnova Ventures, Alkermes plc, Bay City Capital, Canaan Partners, ... [Published PE Hub Blog - Aug 26 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Canaan, Correlation Ventures in $24m Series B for pharma company

Canaan Partners and Correlation Ventures have re-upped in a $24m Series B financing round for medical company Aldea Pharmaceuticals .Healthcare-focused RusnanoMedInvest and WuXi PharmaTech Corporate Ventures invested in the company for the first time ... [Published AltAssets.net - Aug 26 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 5 reports

Aldea Pharmaceuticals Takes $24M

Redwood City-based Aldea Pharmaceuticals said this morning that it has raised $24M in a Series B funding round. The funding came from RusnanoMedInvest (RMI) and WuXi PharmaTech Corporate Ventures, along with prior investors Canaan Partners and Correlation ... [Published Silicontap - Aug 25 2014]
First reported Aug 24 2014 - Updated Aug 24 2014 - 1 reports

Canaan Partners targets $600 mln for Fund X

31 July 2014‘Fundraising will go fast’ for early-stage tech, healthcare investor, LP saysThis content is for Subscribers onlyTo access full Private Markets story content you must be a subscriber. Please use the following link to request your Trial Access ... [Published Venture Capital Journal - Aug 24 2014]
First reported Aug 20 2014 - Updated Aug 21 2014 - 2 reports

Dermira secures $51m Series from new and existing backers

Medical dermatology products maker Dermira has secured $51m in a Series C round backed by new and existing backers.Bay City Capital, New Enterprise Associates, Canaan Partners and UCB participated in the round alongside new investors Apple Tree Partners, ... [Published AltAssets.net - Aug 21 2014]

Quotes

...echnologies have virtually no limit in their potential to create significant opportunities," said Stephen Bloch, General Partner at Canaan Partners. "Liquidia's second spin-out, Lq3 Pharmaceuticals, is a testament to the strength of our investment thesis, as well as the remarkable power and flexibility of the PRINT technology that can be leveraged to develop novel therapeutics across a vast pharmaceutical landscape."
Manu Agarwal, founder and chief executive, Naaptol said, "Though there is enough room for growth in India, we are keen on the neighbouring markets where a large number of Indians live. We may either set up our own business or partner with local players. The discussions are at preliminary stages."
...Bennett said, "The reform constitutes a revolution that is taking place for the first time, after 20 years of the Office of the Chief Scientist. It will shorten processes and provide the right toolbox for enhancing Israeli innovation and bolstering economic growth. Together with the Angels Law, the reform will release a huge amount of energy into the Israeli high-tech market. The tools now available to the Chief Scientist are like an old-fashioned dial phone in the iPhone 6 era. As an ex-high tech company CEO, I didn't use the tools then offered by the Chief Scientist, because they weren't suitable for my company. With the coming reform, the Office of the Chief Scientist will operate at a real high tech pace, and will take this sector 20-25 years ahead into the future in Israel through its flexibility and the diverse and up-to-date facilities it offers."
Harel added, "The UK investors joining the program will enjoy the many private investors from Israel and the world that are active in PrivatEquity.biz.”"

More Content

All (192) | News (80) | Reports (0) | Blogs (111) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Liquidia Technologies Debuts Pharmaceutical Com... [Published Individual.com - 13 hours ago]
Naaptol eyes global footprint in TV shopping [Published Business Standard India - 22 hours ago]
Fitterli wins Intel Business Challenge Europe [Published Globes - Sep 15 2014]
Raleigh-Durham Roundup: Liquidia, TrueBridge, C... [Published Xconomy - Sep 15 2014]
Parkinson's biotech Civitas Therapeutics sets t... [Published Renaissance Capital - Sep 15 2014]
Crowdfunding site Indiegogo opens Israel office [Published Globes - Sep 14 2014]
Bennett unveils plan to revamp aid to Israel's ... [Published Globes - Sep 11 2014]
The investment banker knows how to maximize value [Published Globes - Sep 11 2014]
PrivatEquity.biz expands to UK [Published Globes - Sep 11 2014]
Liquidia Launches Lq3 Pharmaceuticals With $10M... [Published Dow Jones Financial Information Services - Sep 10 2014]
Liquidia's spin-out cycle 2: Another new ventur... [Published Local Tech Wire - Sep 10 2014]
7 start-ups advance to The Pitch finals [Globes... [Published BusinessWeek - Sep 10 2014]
7 start-ups advance to The Pitch finals [Published Globes - Sep 10 2014]
Durham's Liquidia spins out second compay; rais... [Published Triangle Business Journal - Sep 10 2014]
Liquidia Announces Formation of Lq3 Pharmaceuti... [Published Business Wire Technology News - Sep 10 2014]
Liquidia Announces Formation of Lq3 Pharmaceuti... [Published Business Wire Health News - Sep 10 2014]
Rakuten buys cash-back shopping site Ebates for... [Published Vator.tv - Sep 09 2014]
Rakuten buys Ebates for USD 1 bln cash [Published Telecompaper - Sep 09 2014]
Rakuten Confirms Talks to Buy Ebates [Published The Valley Dispatch - Sep 08 2014]
Civitas Therapeutics Secures $55 Million in Ser... [Published Pharmacy Choice - Sep 08 2014]
Kabam Gets Medieval with Strategy Wargame, King... [Published TickerTech.com - Sep 04 2014]
LendingClub Files For IPO [Published Silicontap - Sep 02 2014]
Biotech Sector Rebounds: Earnings Forecasts Are... [Published Epoch Times - Sep 02 2014]
Russian VC invests in U.S. aldehyde metabolism ... [Published Marchmont.ru - Sep 01 2014]
TECHNOLOGY APPREHENDS TO NEXT GENERATION OF BUS... [Published Silicon India - Sep 01 2014]
Biotech IPO fever continues, but fintech coming... [Published PE Hub Blog - Aug 29 2014]
East Coast Biotech Roundup: Biogen, Civitas, Rh... [Published Xconomy - Aug 29 2014]
VC-backed peer-to-peer lender LendingClub files... [Published AltAssets.net - Aug 28 2014]
Pre-VC rounds are shaking up early-stage funding [Published Impact Lab - Aug 28 2014]
Civitas Therapeutics Completes $55M in Series C... [Published Individual.com - Aug 28 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Liquidia Announces Formation of Lq3 Pharmaceuti... [Published Business Wire Technology News - Sep 10 2014]
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies today announced the formation of a new pharmaceutical company, Lq3 Pharmaceuticals, dedicated to advancing novel therapies for oral health conditions. Leveraging the PRINT® (Particle ...
Liquidia Announces Formation of Lq3 Pharmaceuti... [Published Business Wire Health News - Sep 10 2014]
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies today announced the formation of a new pharmaceutical company, Lq3 Pharmaceuticals, dedicated to advancing novel therapies for oral health conditions. Leveraging the PRINT® (Particle ...
Biotech IPO fever continues, but fintech coming... [Published PE Hub Blog - Aug 29 2014]
Enthusiasm over venture-backed biotech IPOs has continued at a fever pitch this summer. In June and July, 17 of the 22 IPOs, or more than three out of four, were biotech startups. That continues a theme that the market has seen all year long with VC-backed ...
Lending Club Files for IPO; Startup Emerged Dur... [Published WSJ.com: Venture Capital Dispatch - Aug 27 2014]
LendingClub Corp. founder and Chief Executive Renaud LaplancheLendingClub Lending Club Corp. on Wednesday filed for an initial public offering, a deal that’s likely to be closely watched as online nonbank lenders continue to gain market share from ...
Civitas Therapeutics scores $55 mln Series C [Published PE Hub Blog - Aug 26 2014]
Civitas Therapeutics has closed $55 million in Series C funding. The investors included Adage Capital Management, OrbiMed Advisors, Partner Fund Management, Rock Springs Capital, Sofinnova Ventures, Alkermes plc, Bay City Capital, Canaan Partners, ...
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.